Maxcyte (MXCT) Long-Term Investments (2023 - 2026)

Maxcyte (MXCT) has 4 years of Long-Term Investments data on file, last reported at $40.8 million in Q1 2026.

• Long-Term Investments for Q1 2026 came in at $40.8 million, up 12.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $40.8 million (up 12.05% YoY), and the FY2025 annual result was $52.6 million, up 46.92% from the prior year.
• Long-Term Investments slipped to $40.8 million in Q1 2026 per MXCT's latest filing, from $52.6 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $52.6 million in Q4 2025 and troughed at $18.4 million in Q3 2023.
• A 4-year average of $40.7 million and a median of $42.5 million in 2024 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2024 and 2025: Long-Term Investments soared 132.23% in 2024, then dropped 19.12% in 2025.
• A 4-year view of Long-Term Investments shows it stood at $42.9 million in 2023, then retreated by 16.67% to $35.8 million in 2024, then soared by 46.92% to $52.6 million in 2025, then dropped by 22.37% to $40.8 million in 2026.
• Business Quant data shows MXCT's Long-Term Investments at $40.8 million in Q1 2026, $52.6 million in Q4 2025, and $52.3 million in Q3 2025.